Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership78,475 shares
Latest Disclosed Value $ 1,875,552
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in PCRX / Pacira BioSciences, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 78,475 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $1,875,552 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 78,475 shares of Pacira BioSciences, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,785,306 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Pacira BioSciences EC US6951271005 78,475 0 0.00 1,876 -3.85 0.0421
2025-05-28 2025-03-31 NP Pacira BioSciences EC US6951271005 78,475 1,713 2.23 1,950 34.85 0.0468
2025-02-25 2024-12-31 NP Pacira BioSciences EC US6951271005 76,762 -14,610 -15.99 1,446 5.16 0.0316
2024-11-26 2024-09-30 NP Pacira BioSciences EC US6951271005 91,372 4,843 5.60 1,375 -44.44 0.0260
2024-08-26 2024-06-30 NP Pacira BioSciences EC US6951271005 86,529 6,519 8.15 2,476 5.91 0.0504
2024-05-28 2024-03-31 NP Pacira BioSciences EC US6951271005 80,010 -3,822 -4.56 2,338 -17.36 0.0488
2024-02-26 2023-12-31 NP Pacira BioSciences EC US6951271005 83,832 6,583 8.52 2,828 19.38 0.0604
2023-11-28 2023-09-30 NP Pacira BioSciences EC US6951271005 77,249 -1,520 -1.93 2,370 -24.94 0.0618
2023-08-25 2023-06-30 NP Pacira BioSciences EC US6951271005 78,769 7,372 10.33 3,156 8.34 0.0749
2023-05-26 2023-03-31 NP Pacira BioSciences EC US6951271005 71,397 513 0.72 2,914 6.47 0.0776
2023-02-24 2022-12-31 NP Pacira BioSciences EC US6951271005 70,884 -142 -0.20 2,737 -27.56 0.0753
2022-11-25 2022-09-30 NP Pacira BioSciences EC US6951271005 71,026 625 0.89 3,778 -7.97 0.1082
2022-08-25 2022-06-30 NP Pacira BioSciences EC US6951271005 70,401 1,801 2.63 4,104 -21.60 0.1133
2022-05-26 2022-03-31 NP Pacira BioSciences EC US6951271005 68,600 1,307 1.94 5,236 29.29 0.1220
2022-02-25 2021-12-31 NP Pacira BioSciences EC US6951271005 67,293 0 0.00 4,049 7.46 0.0878
2021-11-24 2021-09-30 NP Pacira BioSciences EC US6951271005 67,293 0 0.00 3,768 -7.71 0.0830
2021-08-26 2021-06-30 NP Pacira BioSciences EC US6951271005 67,293 2,441 3.76 4,083 -10.17 0.0876
2021-05-27 2021-03-31 NP Pacira BioSciences EC US6951271005 64,852 -987 -1.50 4,545 15.38 0.1031
2021-02-25 2020-12-31 NP Pacira BioSciences EC US6951271005 65,839 -2,342 -3.43 3,940 -3.90 0.1009
2020-11-25 2020-09-30 NP Pacira BioSciences EC US6951271005 68,181 -1,580 -2.26 4,099 11.99 0.1315
2020-08-27 2020-06-30 NP Pacira BioSciences EC US6951271005 69,761 2,892 4.32 3,660 63.25 0.1196
2020-06-01 2020-03-31 NP Pacira BioSciences EC US6951271005 66,869 5 0.01 2,242 -25.96 0.0917
2020-02-27 2019-12-31 NP Pacira BioSciences EC 695127100 66,864 4,903 7.91 3,029 28.41 0.0911
2019-11-27 2019-09-30 NP Pacira BioSciences EC US6951271005 61,961 61,961 2,359 0.0780
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.